Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis.

Kieliszek M, Lipinski B.

Med Hypotheses. 2018 Jan;110:15-22. doi: 10.1016/j.mehy.2017.10.021. Epub 2017 Dec 22. Review.

PMID:
29317059
2.

Application of Sodium Selenite in the Prevention and Treatment of Cancers.

Kieliszek M, Lipinski B, Błażejak S.

Cells. 2017 Oct 24;6(4). pii: E39. doi: 10.3390/cells6040039. Review.

3.

Sodium Selenite as an Anticancer Agent.

Lipinski B.

Anticancer Agents Med Chem. 2017;17(5):658-661. doi: 10.2174/1871520616666160607011024. Review.

PMID:
27281365
4.

Physiochemical basis of human degenerative disease.

Zeliger HI, Lipinski B.

Interdiscip Toxicol. 2015 Mar;8(1):15-21. doi: 10.1515/intox-2015-0003.

5.

Iron-induced fibrin formation may explain vascular pathology in Alzheimer's disease.

Lipinski B, Pretorius E.

Folia Neuropathol. 2014;52(2):205. No abstract available.

6.

Cancer wars: significance of protein unfolding in cancer and its inhibition with natural amphiphilic substances.

Lipinski B.

Front Oncol. 2014 Jul 11;4:183. doi: 10.3389/fonc.2014.00183. eCollection 2014. Review. No abstract available.

7.

Iron-induced parafibrin formation in tumors fosters immune evasion.

Lipinski B.

Oncoimmunology. 2014 Apr 25;3:e28539. eCollection 2014.

8.

Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.

Pretorius E, Bester J, Vermeulen N, Lipinski B, Gericke GS, Kell DB.

PLoS One. 2014 Jan 9;9(1):e85271. doi: 10.1371/journal.pone.0085271. eCollection 2014.

9.

High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease.

Bester J, Buys AV, Lipinski B, Kell DB, Pretorius E.

Front Aging Neurosci. 2013 Dec 6;5:88. doi: 10.3389/fnagi.2013.00088. eCollection 2013.

10.

Unusual clotting dynamics of plasma supplemented with iron(III).

Jankun J, Landeta P, Pretorius E, Skrzypczak-Jankun E, Lipinski B.

Int J Mol Med. 2014 Feb;33(2):367-72. doi: 10.3892/ijmm.2013.1585. Epub 2013 Dec 11.

PMID:
24337469
11.

The role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesium.

Lipinski B, Pretorius E.

Front Hum Neurosci. 2013 Oct 29;7:735. doi: 10.3389/fnhum.2013.00735. Review.

12.

Iron-induced fibrin in cardiovascular disease.

Lipinski B, Pretorius E.

Curr Neurovasc Res. 2013 Aug;10(3):269-74. Review.

13.

Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes.

Pretorius E, Lipinski B, Bester J, Vermeulen N, Soma P.

Ultrastruct Pathol. 2013 Aug;37(4):254-7. doi: 10.3109/01913123.2013.778929. Epub 2013 May 14.

PMID:
23672265
14.

Iron alters red blood cell morphology.

Pretorius E, Lipinski B.

Blood. 2013 Jan 3;121(1):9. No abstract available. Retraction in: Blood. 2014 Mar 13;123(11):1769.

15.

Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study.

Buys AV, Van Rooy MJ, Soma P, Van Papendorp D, Lipinski B, Pretorius E.

Cardiovasc Diabetol. 2013 Jan 28;12:25. doi: 10.1186/1475-2840-12-25.

16.

Thromboembolic ischemic stroke changes red blood cell morphology.

Pretorius E, Lipinski B.

Cardiovasc Pathol. 2013 May-Jun;22(3):241-2. doi: 10.1016/j.carpath.2012.11.005. Epub 2013 Jan 9.

PMID:
23312065
17.

Novel use of scanning electron microscopy for detection of iron-induced morphological changes in human blood.

Pretorius E, Vermeulen N, Bester J, Lipinski B.

Microsc Res Tech. 2013 Mar;76(3):268-71. doi: 10.1002/jemt.22163. Epub 2012 Dec 28.

PMID:
23280783
18.

A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy.

Pretorius E, Vermeulen N, Bester J, Lipinski B, Kell DB.

Toxicol Mech Methods. 2013 Jun;23(5):352-9. doi: 10.3109/15376516.2012.762082. Epub 2013 Apr 19.

PMID:
23278212
19.

Differences in morphology of fibrin clots induced with thrombin and ferric ions and its pathophysiological consequences.

Pretorius E, Lipinski B.

Heart Lung Circ. 2013 Jun;22(6):447-9. doi: 10.1016/j.hlc.2012.10.010. Epub 2012 Dec 7.

PMID:
23219312
20.

Oxidation inhibits iron-induced blood coagulation.

Pretorius E, Bester J, Vermeulen N, Lipinski B.

Curr Drug Targets. 2013 Jan 1;14(1):13-9.

21.

Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron.

Lipinski B, Pretorius E.

Hematology. 2012 Jul;17(4):241-7. doi: 10.1179/1607845412Y.0000000004.

PMID:
22889519
22.

Iron enhances generation of fibrin fibers in human blood: implications for pathogenesis of stroke.

Lipinski B, Pretorius E, Oberholzer HM, Van Der Spuy WJ.

Microsc Res Tech. 2012 Sep;75(9):1185-90. doi: 10.1002/jemt.22047. Epub 2012 Apr 5.

PMID:
22488824
23.

Interaction of fibrin with red blood cells: the role of iron.

Lipinski B, Pretorius E, Oberholzer HM, van der Spuy WJ.

Ultrastruct Pathol. 2012 Apr;36(2):79-84. doi: 10.3109/01913123.2011.627491. Erratum in: Ultrastruct Pathol. 2012 Aug;36(4):286.

PMID:
22471429
24.
25.

Hydroxyl radical and its scavengers in health and disease.

Lipinski B.

Oxid Med Cell Longev. 2011;2011:809696. doi: 10.1155/2011/809696. Epub 2011 Jul 17. Review.

26.

Modification of fibrin structure as a possible cause of thrombolytic resistance.

Lipinski B.

J Thromb Thrombolysis. 2010 Apr;29(3):296-8. doi: 10.1007/s11239-009-0367-6. Review.

PMID:
19551349
27.

Potential Role of Oxidative Stress in Mediating the Effect of Altered Gravity on the Developing Rat Cerebellum.

Sajdel-Sulkowska EM, Nguon K, Sulkowski ZL, Lipinski B.

Adv Space Res. 2007;40(9):1414-1420.

28.

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics.

Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2008 Apr;19(4):789-97. doi: 10.1681/ASN.2007050556. Epub 2008 Feb 6.

29.

New insight into Alzheimer disease: demonstration of fibrin(ogen)-serum albumin insoluble deposits in brain tissue.

Lipinski B, Sajdel-Sulkowska EM.

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):323-6. No abstract available.

PMID:
17132984
30.

Risk factors for thromboembolic events in renal failure.

D'Elia JA, Weinrauch LA, Gleason RE, Lipinska I, Lipinski B, Lee AT, Tofler GH.

Int J Cardiol. 2005 May 11;101(1):19-25.

PMID:
15860378
31.

Rationale for the treatment of cancer with sodium selenite.

Lipinski B.

Med Hypotheses. 2005;64(4):806-10.

PMID:
15694701
32.

Re: Science peels the onion of selenium effects on prostate carcinogenesis.

Lipinski B.

J Natl Cancer Inst. 2004 Nov 3;96(21):1640. No abstract available.

PMID:
15523095
33.

Markers of oxidative stress in uremia.

Lipinski B.

Kidney Int. 2004 Jan;65(1):339-40; author reply 340. No abstract available.

34.

Evidence in support of a concept of reductive stress.

Lipinski B.

Br J Nutr. 2002 Jan;87(1):93-4; discussion 94. No abstract available.

PMID:
11895317
35.

Is the macromolecular protein complex (MPC) a marker for oxidative stress in diabetes mellitus?

Lipinski B, Lipinska I, Kato Y.

Diabetologia. 2001 Oct;44(10):1356. No abstract available.

PMID:
11692188
36.

Pathophysiology of oxidative stress in diabetes mellitus.

Lipinski B.

J Diabetes Complications. 2001 Jul-Aug;15(4):203-10. Review.

PMID:
11457673
37.
38.

Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen.

Lipinski B, Lipinska I.

Magnes Res. 2000 Dec;13(4):233-7.

PMID:
11153893
39.

Resistance of cancer cells to immune recognition and killing.

Lipinski B, Egyud LG.

Med Hypotheses. 2000 Mar;54(3):456-60.

PMID:
10783488
40.

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F.

Biol Psychiatry. 2000 Feb 15;47(4):305-13.

PMID:
10686265
41.

Signal undershoots following visual stimulation: a comparison of gradient and spin-echo BOLD sequences.

Jones RA, Schirmer T, Lipinski B, Elbel GK, Auer DP.

Magn Reson Med. 1998 Jul;40(1):112-8.

PMID:
9660561
42.

Macromolecular protein complex in human plasma may explain altered fibrin gel structure in IDDM patients.

Lipinski B, Krolewski AS.

Diabetologia. 1997 Jul;40(7):869. No abstract available.

PMID:
9243113
43.

Expectation maximization reconstruction of positron emission tomography images using anatomical magnetic resonance information.

Lipinski B, Herzog H, Rota Kops E, Oberschelp W, Müller-Gärtner HW.

IEEE Trans Med Imaging. 1997 Apr;16(2):129-36.

PMID:
9101322
44.

Ticlopidine may reduce functional fibrinogen levels by inhibition of MPC incorporation into fibrin.

Lipinski B, Krolewski AS.

Thromb Haemost. 1997 Mar;77(3):603-4. No abstract available.

PMID:
9066019
45.

Further discussion on foundation for acupuncture.

Lipinski B.

Altern Ther Health Med. 1996 Jan;2(1):14. No abstract available.

PMID:
8795869
46.

Does albumin affect clotting of fibrinogen with thrombin?

Lipinski B.

Thromb Haemost. 1995 Oct;74(4):1206. No abstract available.

PMID:
8560443
47.

Methods of plasma fibrinogen measurement and dietary modification.

Lipinski B.

Am J Clin Nutr. 1995 Aug;62(2):441-2. No abstract available.

PMID:
7625355
48.

Plasma macromolecular protein complex: interaction with fibrin and fibrinolysis.

Lipinski B, Federman SM, Krolewski AS.

Thromb Res. 1995 Jun 1;78(5):461-5. No abstract available.

PMID:
7660362
49.
50.

Aurin tricarboxylic acid inhibits fibrinogen clotting with thrombin by forming soluble fibrin complexes.

Lipinski B.

Thromb Res. 1995 Feb 15;77(4):379-80. No abstract available.

PMID:
7740529

Supplemental Content

Loading ...
Support Center